A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Medicines Agency (EMA) has ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the Committee for Orphan Medicinal Products (COMP) of the ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the ...

The increasing use of diabetes drug Ozempic as a weight-loss treatment prompted the European Medicines Agency to urge doctors to prioritize the injection made by Novo Nordisk A/S for diabetics ...

However, the European Medicines Agency (EMA), against all odds, has refused to authorize its marketing. After almost two years of trying to get the agency to see reason, PharmaMar sued the ...

Over the past 4 years, we at the European Medicines Agency (EMA) have set new standards for clinical trial data transparency by adopting two landmark policies. A 2010 policy on access to documents ...